オメガ3の世界市場規模：タイプ別、由来別、用途別、地域別、範囲および予測

オメガ3の市場規模と予測

オメガ3市場規模は2021年に21億米ドルと評価され、2022年から2030年にかけてCAGR 8.21％で成長し、2030年には39億3,000万米ドルに達すると予測されます。消費者の間で健康的な食事とオメガ3の健康上の利点に関する意識の高まりと臨床研究開発への投資の増加は、予測される数年間でオメガ3市場を促進すると予想されます。オメガ3の世界市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界のオメガ3市場の定義

オメガ3脂肪酸は、心疾患の危険性を減らし、健康的な皮膚を促進します。オメガ3脂肪酸は、食事や運動と組み合わせて摂取することで、血中脂肪（トリグリセリド）のレベルを下げ、「善玉」コレステロール（HDL）のレベルを高める。また、高血圧や自己免疫疾患を促進するためにも使用されます。オメガ3市場は、慢性疾患の増加とともに変化し続けています。これは、オメガ3脂肪酸（DHA）、オメガ3（EPA）、オメガ3（ALA）と一緒に並べ替えをサポートするように分類されます。

世界のオメガ3市場概要

顧客の間で多価不飽和脂肪酸の健康的な摂食＆健康的な縁に関連する意識の高まりと臨床分析＆市場開拓エリアユニットへの投資の増加は、予想される数年間でオメガ3市場を促進することが期待されています。また、医薬品有効成分（API）内の製品の使用量の増加と慢性疾患の意識の高まりは、今後数年間で市場を持ち上げることを期待しています。

さらに、オメガ3が免疫力を高め、犬猫の悪性疾患や炎症性内臓疾患のような慢性疾患を予防する力は、予測期間を通じて市場を活性化すると予測されています。市場の成長を阻害する可能性のある二面的な課題も存在します。厳しい規制障壁やオメガ3領域ユニットに関するより良い価格のような要因は、間違いなく市場抑制要因として作用します。

目次

第1章 世界のオメガ3市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• 検証
• 一次資料
• データソース一覧

第4章 世界のオメガ3市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界のオメガ3市場、タイプ別

• 概要
• ドコサヘキサエン酸（DHA）
• エイコサペンタエン酸（EPA）
• α-リノレン酸（Ala）

第6章 オメガ3の世界市場：由来別

• 概要
• 海洋由来
• 植物由来

第7章 オメガ3の世界市場、用途別

• 概要
• 栄養補助食品
• 機能性飲食品
• 医薬品
• その他

第8章 オメガ3の世界市場、地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界のオメガ3市場の競合情勢

• 概要
• 企業の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• CRODA INTERNATIONAL
• DSM
• LONZA
• ORKLA HEALTH
• CARGILL
• CORBION
• GC RIEBER
• BASF
• KD PHARMA
• EPAX

第11章 付録

• 関連調査

Omega 3 Market Size And Forecast

Omega 3 Market size was valued at USD 2.10 Billion in 2021 and is projected to reach USD 3.93 Billion by 2030 , growing at a CAGR of 8.21% from 2022 to 2030. Rising awareness regarding healthy eating & health benefits of omega-3 among consumers and increasing investment in clinical research & development are expected to drive the Omega 3 Market over the predicted years. The Global Omega 3 Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Omega 3 Market Definition

Omega-3 fatty acids facilitate cut back the danger of cardiopathy and promote healthy skin. This area unit intake in conjunction with diet and exercise to assist lower levels of sure blood fat (triglyceride) and boost levels of "good" cholesteric (HDL). Moreover, it's conjointly wanted to facilitate high-pressure or autoimmune disorders. The ever-changing manner, in conjunction with rising chronic diseases, has contributed to the expansion of the Omega 3 Market. It's classified as supporting the sort together with omega-3 fatty acid (DHA), omega-3 (EPA), and omega-3 (ALA).

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Omega 3 Market Overview

Rising awareness relating to healthy feeding & healthy edges of polyunsaturated fatty acid among customers and increasing investment in clinical analysis & development area units are expected to drive the Omega-3 Market over the expected years. Also, the growing product usage within the Active Pharmaceutical Ingredient (API) and rising awareness of chronic diseases expect to lift the market within the coming years.

Additionally, the power of omega-3 to boost immunity & forestall chronic conditions like malady} & inflammatory internal organ disease in cats and dogs is foretold to fuel the market throughout the forecasted period. There are area unit sure restraints and challenges two-faced which might hinder the market growth. Factors like strict regulation barriers and better prices related to omega-three area units doubtless act as market restraints.

Global Omega 3 Market: Segmentation Analysis

The Global Omega 3 Market is Segmented on the basis of Type, Source, Application, and Geography.

Omega 3 Market, By Type

• Docosahexaenoic Acid (DHA)
• Eicosapentaenoic Acid (EPA)
• Alpha-linolenic Acid (ALA)
• Based on Type, the market is segmented into
• Docosahexaenoic Acid (DHA)
• , Eicosapentaenoic Acid (EPA), and Alpha-linolenic Acid (ALA). Docosahexaenoic Acid (DHA) is predicted to carry the most important market share because of the growing demand for kid formula, which helps in memory retention and learning. Also, it plays a significant role in developing nerve and eye tissues. Global Omega 3 Market, by source

Omega 3 Market, By Source

• Marine Source
• Plant Source

Based on Source, the market is segmented into Marine Source and Plant Source. The marine supply is foretold to carry the foremost important CAGR within the forecasted period as DHA and Environmental Protection Agency area unit synthesized by living thing marine organisms like planktons & Protoctista. The consumption of those organisms helps accumulate polyunsaturated fatty acid fatty acids within the body.

Omega 3 Market, By Application

• Dietary Supplements
• Functional Food & Beverages
• Pharmaceuticals
• Others
• Based on Application, the market is segmented into
• Dietary Supplements
• , Functional Food & Beverages, Pharmaceuticals, and Others. Dietary supplements are units anticipated to own the very best CAGR within the forecasted amount as they're targeted sources of nutrients or alternative substances with an organic process or physiological result.

Omega 3 Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, the Global Omega 3 Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The most important share within the market will be dominated by the Asia Pacific, attributable to the upper demand for fortified food products and the advancements in food technology.

Key Players

• The "Global Omega 3 Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
• Croda International, DSM, Lonza, Orkla Health, Cargill, Corbion, GC Rieber, BASF, KD Pharma, and EPAx.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Partnerships, Collaborations and Agreements
• On November 2020, Croda International had inked a collaborative partnership with Anomera, an innovative green chemistry Canadian company based in Quebec, focused on developing high-quality Carboxylated Cellulose Nanocrystals which are converted into a micron-sized powder.
• On January 2021, Croda International Plc, the specialty chemical company that uses innovative science to create high-performance ingredients and technologies that improve lives, announced a global sales and marketing agreement with Genesis Biosciences. This new partnership further expands Croda's existing portfolio of safe and sustainable cleaning raw materials.
• On June 2021, Lonza and Moderna Announced a Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands. A new drug substance production line at Lonza's site in Geleen, Netherlands, will complement the existing production network and support the manufacture of up to an additional 300 million doses per year.
• On July 2021, Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply. Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain to manufacture an antibody-drug conjugate for use against hard-to-treat cancers.
• Mergers and Acquisitions
• On April 2021, The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The acquisitions give KD Pharma access to technology for producing Active Pharmaceutical Ingredients based on phytocannabinoids and other plant extracts.
• On June 2021, Orkla Health acquired NutraQ, and The acquisition will offer Orkla exciting growth opportunities. The health category and direct-to-consumer sales are growing areas and will continue to develop NutraQ's vital concepts while also exploring new possibilities for direct-to-consumer sales.
• On August 2021, Corbion announced it had acquired Granolife, a Queretaro, Mexico-based provider of functional blends for the Mexican bakery and fortification industries. Granolife employs approximately 60 at its production facility and application in the development center.
• Product Launches and Product Expansions
• On January 2021, Corbion increased its capacity for producing lactic acid in North America by around 40% to meet the growing demand for natural ingredients in multiple industries. The investment reinforces the company's leadership position as a supplier of lactic acid and its derivatives worldwide. Corbion also operates lactic acid production facilities in the Netherlands, Brazil, Spain, and Thailand.

TABLE OF CONTENTS

1 INTRODUCTION TO GLOBAL OMEGA 3 MARKET

• 1.1 OVERVIEW OF THE MARKET
• 1.2 SCOPE OF REPORT
• 1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 DATA MINING
• 3.2 VALIDATION
• 3.3 PRIMARY INTERVIEWS
• 3.4 LIST OF DATA SOURCES

4 GLOBAL OMEGA 3 MARKET OUTLOOK

• 4.1 OVERVIEW
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
  • 4.2.2 RESTRAINTS
  • 4.2.3 OPPORTUNITIES
• 4.3 PORTERS FIVE FORCE MODEL
• 4.4 VALUE CHAIN ANALYSIS

5 GLOBAL OMEGA 3 MARKET, BY TYPE

• 5.1 OVERVIEW
• 5.2 DOCOSAHEXAENOIC ACID (DHA)
• 5.3 EICOSAPENTAENOIC ACID (EPA)
• 5.4 ALPHA-LINOLENIC ACID (ALA)

6 GLOBAL OMEGA 3 MARKET, BY SOURCE

• 6.1 OVERVIEW
• 6.2 MARINE SOURCE
• 6.3 PLANT SOURCE

7 GLOBAL OMEGA 3 MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 DIETARY SUPPLEMENTS
• 7.3 FUNCTIONAL FOOD & BEVERAGES
• 7.4 PHARMACEUTICALS
• 7.5 OTHERS

8 GLOBAL OMEGA 3 MARKET, BY GEOGRAPHY

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 U.S.
  • 8.2.2 CANADA
  • 8.2.3 MEXICO
• 8.3 EUROPE
  • 8.3.1 GERMANY
  • 8.3.2 U.K.
  • 8.3.3 FRANCE
  • 8.3.4 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 CHINA
  • 8.4.2 JAPAN
  • 8.4.3 INDIA
  • 8.4.4 REST OF ASIA PACIFIC
• 8.5 REST OF THE WORLD
  • 8.5.1 LATIN AMERICA
  • 8.5.2 MIDDLE EAST & AFRICA

9 GLOBAL OMEGA 3 MARKET COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 COMPANY MARKET RANKING
• 9.3 KEY DEVELOPMENT STRATEGIES

10 COMPANY PROFILES

• 10.1 CRODA INTERNATIONAL
  • 10.1.1 OVERVIEW
  • 10.1.2 FINANCIAL PERFORMANCE
  • 10.1.3 PRODUCT OUTLOOK
  • 10.1.4 KEY DEVELOPMENTS
• 10.2 DSM
  • 10.2.1 OVERVIEW
  • 10.2.2 FINANCIAL PERFORMANCE
  • 10.2.3 PRODUCT OUTLOOK
  • 10.2.4 KEY DEVELOPMENTS
• 10.3 LONZA
  • 10.3.1 OVERVIEW
  • 10.3.2 FINANCIAL PERFORMANCE
  • 10.3.3 PRODUCT OUTLOOK
  • 10.3.4 KEY DEVELOPMENTS
• 10.4 ORKLA HEALTH
  • 10.4.1 OVERVIEW
  • 10.4.2 FINANCIAL PERFORMANCE
  • 10.4.3 PRODUCT OUTLOOK
  • 10.4.4 KEY DEVELOPMENTS
• 10.5 CARGILL
  • 10.5.1 OVERVIEW
  • 10.5.2 FINANCIAL PERFORMANCE
  • 10.5.3 PRODUCT OUTLOOK
  • 10.5.4 KEY DEVELOPMENTS
• 10.6 CORBION
  • 10.6.1 OVERVIEW
  • 10.6.2 FINANCIAL PERFORMANCE
  • 10.6.3 PRODUCT OUTLOOK
  • 10.6.4 KEY DEVELOPMENTS
• 10.7 GC RIEBER
  • 10.7.1 OVERVIEW
  • 10.7.2 FINANCIAL PERFORMANCE
  • 10.7.3 PRODUCT OUTLOOK
  • 10.7.4 KEY DEVELOPMENTS
• 10.8 BASF
  • 10.8.1 OVERVIEW
  • 10.8.2 FINANCIAL PERFORMANCE
  • 10.8.3 PRODUCT OUTLOOK
  • 10.8.4 KEY DEVELOPMENTS
• 10.9 KD PHARMA
  • 10.9.1 OVERVIEW
  • 10.9.2 FINANCIAL PERFORMANCE
  • 10.9.3 PRODUCT OUTLOOK
  • 10.9.4 KEY DEVELOPMENTS
• 10.10 EPAX
  • 10.10.1 OVERVIEW
  • 10.10.2 FINANCIAL PERFORMANCE
  • 10.10.3 PRODUCT OUTLOOK
  • 10.10.4 KEY DEVELOPMENTS

11 APPENDIX

• 11.1 RELATED RESEARCH